Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/5268
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorBrites, Carlos-
dc.contributor.authorMartins Netto, Eduardo-
dc.contributor.authorJorge, Célia Regina Mayoral Pedroso-
dc.contributor.authorSampaio, Diana Brasil Pedral-
dc.contributor.authorHarrington Júnior, W.-
dc.contributor.authorGoyanna, F.-
dc.contributor.authorAdriano, S.-
dc.creatorBrites, Carlos-
dc.creatorMartins Netto, Eduardo-
dc.creatorJorge, Célia Regina Mayoral Pedroso-
dc.creatorSampaio, Diana Brasil Pedral-
dc.creatorHarrington Júnior, W.-
dc.creatorGoyanna, F.-
dc.creatorAdriano, S.-
dc.date.accessioned2012-01-27T12:06:33Z-
dc.date.available2012-01-27T12:06:33Z-
dc.date.issued2011-
dc.identifier.issn1678-4391-
dc.identifier.urihttp://www.repositorio.ufba.br/ri/handle/ri/5268-
dc.descriptionp. 6-11pt_BR
dc.description.abstractObjective: To compare the clinical characteristics and outcomes of HIV-1-HTLV-1 coinfected patients, in Bahia, Brazil. Methods: Retrospective, comparative study. Results: Among a total of 123 consecutive HIV infected patients, 20 men (20.6%) and 6 women (23.1%) had detectable antibodies against HTLV-I/II. The major risk factor associated with coinfection by HTLV was intravenous drug use (57.7% of coinfected patient versus 9.2% of HTLV seronegative patients, p < 0.0001). Coinfected patients had higher absolute lymphocyte counts (1,921 + 762 versus 1,587 + 951, p = 0.03). Both groups of patients had similar means of CD4+ and CD8+ cell counts. However, among patients with AIDS CD4+ cell counts were signifi cantly higher among those coinfected with HTLV-I/II (292 ± 92 cells/mm3, versus 140 ± 177cells/mm3, p = 0.36). The frequency and type of opportunistic infections were similar for both groups, but strongyloidiasis and encephalopathy were more frequently diagnosed in coinfected patients (p < 0.05). On the other hand, patients coinfected with HTLV-I/II received signifi cantly less antiretroviral therapy than singly infected by HIV-1. Conclusion: Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis for HIV patients. Higher CD4 count may lead to underestimation of immunodefi ciency, and delay to initiate antiretroviral therapy.pt_BR
dc.language.isoenpt_BR
dc.subjectHIVpt_BR
dc.subjectHTLV-I/IIpt_BR
dc.subjectcoinfection Strongyloidiasispt_BR
dc.subjectCD4/CD8pt_BR
dc.titleCoinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patientspt_BR
dc.title.alternativeThe Brazilian Journal of Infectious Diseasespt_BR
dc.typeArtigo de Periódicopt_BR
dc.identifier.number15(1)pt_BR
Aparece nas coleções:Artigo Publicado em Periódico Estrangeiro (ISC)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
v15n1a02.pdf285,18 kBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.